who should not take glp-1 receptor agonists Struggling with therapy side effects? You're alone. This Clinician Guide: Managing Common GLP-1 Agonist Side Effects provides practical tips on recognizing, preventing and managing gastrointestinal and nutritional side effects SGLT-2 Inhibitors and GLP-1 Receptor

Commonly prescribed GLP-1 medications include Ozempic (semaglutide) , Mounjaro (tirzepatide) , and their generic alternatives

[44] has highlighted a significant genetic correlation (rg = 0.52, p = 6.4010 12 ) between OSA and T2D, indicating a possible shared genetic foundation for both conditions

These specialized immune cells express GLP-1 receptors and when GLP-1(whether from native production or GLP-1 agonists) activates these IELs via GLP-1R it helps to suppress localized T-cell induced inflammation

The most striking protective effects of SGLT2is were a marked reduction in hospitalization for heart failure and a remarkable reduced progression of chronic kidney disease

Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jni P, Lettino M, Marx N, Mellbin LG, stgren CJ, Rocca B, Roffi M, Sattar N, Seferovi PM, Sousa-Uva M, Valensi P, Wheeler DC, ESC Scientific Document Group